Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the use in this Registration Statement on Form S-1, Pre-Effective Amendment No. 10, for Tibet Pharmaceuticals, Inc. of our audit report dated July 19, 2010, relating to the consolidated financial statements of Tibet Pharmaceuticals, Inc. (formerly named Shangri-La Tibetan Pharmaceuticals, Inc., the “Company”) as of December 31, 2009 and 2008 and for the years then ended, and to the reference to our firm under the heading “Expert” in the prospectus.

/s/    Acquavella, Chiarelli, Shuster, Berkower & Co., LLP

New York, NY

December 15, 2010